Answers are grounded in this paper and cite their sources.
I read with great interest the article by Vigotsky and colleagues on the prognostic value of preoperative mechanical hyperalgesia and neuropathic pain qualities for postoperative pain after total knee replacement (TKR) (Vigotsky et al., 2024) and I would like to stress the importance of understanding pain phenotypes in knee osteoarthritis (KOA) when selecting appropriate pain-management strategies for these patients. Many authors have classically considered KOA to be a type of nociceptive pain. However, the different presentations of pain symptoms in KOA can also identify possible KOA subgroups that require a different treatment strategy. The International Association for the Study of Pain (IASP) recognizes nociceptive (tissue damage), neuropathic (nerve injury) and nociplastic (sensitized nervous system) pain as different types of pain caused by different mechanisms. KOA is probably a syndrome of multiple pathophysiological mechanisms and, over time, patients with KOA will probably suffer nociceptive, neuropathic and nociplastic pain. The pain that patients with KOA experience could be seen as part of a continuum, normally starting with nociceptive pain caused by peripheral tissue damage and persistent inflammation following joint trauma or overload. The joint trauma or overload can directly result in nerve injury or can initiate inflammation that can result in small-fibre neuropathy and neurogenic inflammation. Continuous facilitation of pain through peripheral sensitization and neuroinflammation can result in central sensitization. When there is no clear evidence of tissue damage or nerve damage that causes nociceptor activation, the pain experienced might be the result of a hypersensitive pain system. This state of pain can be characterized as nociplastic. Furthermore, when this continuum of pain types exists (from nociceptive, neuropathic to nociplastic) in KOA, it appears to be logical that there will be mixed pain symptoms and that it will be necessary to start treatment as soon as possible to break this vicious circle. It is known that the increase in the nociceptive neuron response capacity in the central or peripheral nervous system due to central or peripheral sensitization or both is a well-known pathophysiological characteristic of nociceptive and neuropathic pain. Altered nociception, which is also assumed in the pathophysiology of nociplastic pain, is associated with a peripheral and/or central sensitization, which can be clinically differentiated using Quantitative Sensory Testing. As with neuropathic pain, it is important to evaluate central sensitization phenomena in OA, as they can be present in approximately 30% of patients with OA (Lluch et al., 2014), and their presence requires a different therapeutic approach to that of habitual nociceptive pain. To evaluate the central sensitization, the Central Sensitization Inventory (CSI), which scores between 0 and 100, is most useful. A CSI score of 40 or above indicates the presence of pain with central sensitization (Nijs et al., 2021). So, in patients who are candidates for knee replacement, it is important to assess the degree of sensitization prior to surgery, given that the patients with the highest degree of sensitization display slower post-surgical evolution and higher levels of post-surgical pain. Consequently, each type of pain must be identified in KOA patients by means of an exhaustive patient history, a physical examination and diagnostic tests or biomarkers (currently in development) to optimize the efficacy of the treatment. During the course of KOA, patients will probably experience more than one different type of pain (Freynhagen et al., 2020). Consequently, as professionals who care for these patients, we must all be alert not only to adjust their treatment if the underlying pathophysiological mechanisms tend to change, but also to personalize treatment to the associated pain type in patients with KOA. I hope these reflections help classify the different conditions of chronic pain by evaluating pain sensitization characteristics and the three definitions proposed by the IASP (not forgetting ‘mixed pain’) and serve to encourage more in-depth analysis and information to gather new evidence, as well as research which aims to further evaluate the pathogenesis of pain conditions such as KOA.
No takes yet. Share an insight, caveat, or question.
A. Alcántara Montero (2024) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: